Join our API course for an in-depth understanding of active pharmaceutical ingredients in drug manufacturing. Learn the regulatory frameworks of the EU and USA, GMP and GDP practices, and key ...

Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules Pace Life Sciences Salem Renderings ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the potential.

Burkhard has a proven track record in developing tailored enterprise solutions that address complex challenges, including adherence to strict industry standards like CFR 21 Part 11 and cGMP.

The USSR built three twin plants. Volkovysk was chosen the venue for a dairy and baby food canning plant. It supplied ...

Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties ...

VIENNA, Austria I June 30, 2025 I invIOs GmbH (“invIOs”), a privately held biotechnology company focused on developing innovative cancer immunotherapies, ...

U.S. Trade Representative Jamieson Greer made clear in a meeting with Irish Trade Minster Simon Harris last month that ...

While the investigation into the June 30 blast is underway, the company said on Wednesday that it was not a reactor explosion ...

Alphalyse, a fast-growing Danish specialist contract research organization (CRO) that has developed GMP‑validated liquid‑chromatography mass‑spectrometry (LC‑MS) assays for host‑cell‑protein (HCP) ...

A trade organisation representing pharma manufacturers in Europe has said plans to restrict the use of fluorinated substances known as PFAS could make manufacturing “grind to a ...